by Extivita | Apr 28, 2017 | Diabetic Foot Ulcers
Abstract: Worldwide, diabetic foot ulcers (DFUs) continue to exact a major burden on patients and health care providers. Although hyperbaric oxygen therapy is well-known as an adjunct option, less is known about the efficacy of transdermal continuous oxygen therapy...
by Extivita | Jun 9, 2005 | Diabetic Foot Ulcers
Abstract: To compare healing rates at 12 weeks for full-thickness diabetic foot ulcers treated with OASIS Wound Matrix, an acellular wound care product, versus Regranex Gel. Randomized, prospective, controlled multicenter trial at 9 outpatient wound care clinics. A...
by Extivita | Nov 15, 2000 | Diabetic Foot Ulcers
Abstract: Clinical experience with adjunctive hyperbaric oxygen therapy in the treatment of diabetic ulcers has shown that wound hyperoxia increases wound granulation tissue formation and accelerates wound contraction and secondary closure. In addition to wound...
by Extivita | Mar 1, 1991 | Migraines
Abstract: A 20 year old male naval crew-member suffering from sea sickness was treated with transdermal scopolamine (TS). After 5 months of continuous treatment, he developed scopolamine intoxication followed by the appearance of recurrent classic migraine attacks. He...
